Evidence map›Paper›PMID 31167813›Full record

ArticleGut2020

Modulation of cytokine patterns and microbiome during pregnancy in IBD.

Janine van der Giessen, Dana Binyamin, Anna Belogolovski, Sigal Frishman, Kinneret Tenenbaum-Gavish, Eran Hadar, Yoram Louzoun, Maikel Petrus Peppelenbosch, Christien Janneke van der Woude, Omry Koren and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Maternal gut microbiota in the postpartum Period: A Systematic review.European journal of obstetrics, gynecology, and reproductive biology · 2023
    Pooled it
  3. Article
  4. Article
  5. mBio · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Janine van der Giessen *Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Dana Binyamin *Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Anna BelogolovskiDepartment of Mathematics, Bar-Ilan University, Ramat-Gan, Israel.
Sigal FrishmanRabin Medical Center and the Sackler Faculty of Medicine, Tel Aviv university, Tel Aviv, Israel.
Kinneret Tenenbaum-GavishRabin Medical Center and the Sackler Faculty of Medicine, Tel Aviv university, Tel Aviv, Israel.
Eran HadarRabin Medical Center and the Sackler Faculty of Medicine, Tel Aviv university, Tel Aviv, Israel.
Yoram LouzounDepartment of Mathematics, Bar-Ilan University, Ramat-Gan, Israel.
Maikel Petrus PeppelenboschDepartment of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0001-9112-6028
Christien Janneke van der WoudeDepartment of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Omry Koren *Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0002-7738-1337
Gwenny Manel Fuhler *Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0001-9221-4855
Bar-Ilan University · ILErasmus MC · NLRabin Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePregnancy may affect the disease course of IBD. Both pregnancy and IBD are associated with altered immunology and intestinal microbiology. However, to what extent immunological and microbial profiles are affected by pregnancy in patients with IBD remains unclear.

designFaecal and serum samples were collected from 46 IBD patients (31 Crohn's disease (CD) and 15 UC) and 179 healthy controls during first, second and third trimester of pregnancy, and prepregnancy and postpartum for patients with IBD. Peripheral blood cytokine profiles were determined by ELISA, and microbiome analysis was performed by sequencing the V4 region of the bacterial 16S rRNA gene.

resultsProinflammatory serum cytokine levels in patients with IBD decrease significantly on conception. Reduced interleukin (IL)-10 and IL-5 levels but increased IL-8 and interferon (IFN)γ levels compared with healthy controls were seen throughout pregnancy, but cytokine patterns remained stable during gestation. Microbial diversity in pregnant patients with IBD was reduced compared with that in healthy women, and significant differences existed between patients with UC and CD in early pregnancy. However, these microbial differences were no longer present during middle and late pregnancy. Dynamic modelling showed considerable interaction between cytokine and microbial composition.

conclusionSerum proinflammatory cytokine levels markedly improve on conception in pregnant patients with IBD, and intestinal microbiome diversity of patients with IBD normalises during middle and late pregnancy. We thus conclude that pregnancy is safe and even potentially beneficial for patients with IBD.

Indexed as

Gastrointestinal MicrobiomeAdultCase-Control StudiesColitis, UlcerativeCrohn DiseaseCytokinesFecesFemaleHumansInterferon-gammaInterleukin-10Interleukin-5Interleukin-8PregnancyPregnancy ComplicationsPregnancy TrimestersCXCL8 protein, humanCytokinesIL10 protein, humanIL5 protein, humanInterferon-gammaInterleukin-10Interleukin-5Interleukin-8crohn’s diseasecytokinesinflammatory bowel diseaseintestinal microbiologyulcerative colitis

Identifiers

PMID31167813
PMCPMC7034354
OpenAlexW2953628263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.